Anderson Heart Partners with Azura Vascular Care & National Cardiovascular Partners

Anderson Heart, PC (Anderson Heart or AH), an independent cardiology and vascular surgery practice headquartered in Anderson, South Carolina, has partnered with Azura Vascular Care and National Cardiovascular Partners, LP, together wholly owned by Fresenius Medical Care North America, to form a newly created joint venture that completes an equity recapitalization and focuses on a growth strategy of physician recruitment and providing high-quality medical care to patients throughout South Carolina, at the advice of The Capital Corporation

The Capital Corporation, a boutique investment bank headquartered in Greenville, South Carolina, offering particular expertise in the health services sector, served as the exclusive investment banking advisor to Anderson Heart on the transaction.

Anderson Heart was formed in 2006 as an independent cardiology medical practice by founder and current Chief Executive Officer, Dr. Brent McLaurin. Since formation, AH added three additional physicians including one cardiologist and two vascular surgeons. In 2017, AH designed and constructed a wholly-owned, freestanding, independent clinic from which its four physicians conduct their practice of medicine.

Anderson Heart provides the highest-quality medical services to its patients from its owned clinic and local hospitals as necessary. Further, AH does so at lower overall cost to patients and third-party reimbursors such as the Centers for Medicare and Medicaid Services (“CMS”) and numerous independent health insurance companies. CMS is part of the Department of Health and Human Services and oversees the U.S. government’s Medicare and Medicaid programs.

Azura Vascular Care, a division of Fresenius Medical Care North America, is a national leader in the field of vascular specialty services. Operating and managing outpatient vascular care and ambulatory surgery centers throughout the United States and Puerto Rico, Azura’s physicians and trained medical specialists perform minimally invasive procedures focusing on excellence in clinical outcomes and delivering a great customer experience to patients with various vascular conditions that can be treated safely in an outpatient setting.

National Cardiovascular Partners, a division of Fresenius Medical Care North America, partners with physicians to create, sustain and grow independent ambulatory surgery centers and catheterization labs. Its focus is on hybrid surgery center and outpatient cardiac catheterization lab services, in partnership with physician entrepreneurs. NCP currently operates surgery centers and physician practices throughout the U.S. For more information, please visit the NCP website at www.ncplp.com.

The Capital Corporation: Now in its 30th year of operation, The Capital Corporation continues to provide its publicly traded and privately held middle-market client companies quality advisory services to help them achieve their financial objectives. With hundreds of closed transactions, The Capital Corporation is one of the most successful middle-market investment banking firms in the country, differentiated by its team’s experience, commitment, and unwavering focus on achieving client objectives. As a member of IMAP, The Capital Corporation is part of the world’s largest alliance of independent M&A advisory firms offering local expertise and global connections through more than 60 offices in over 40 countries.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”